5 Stocks to Watch Right Now

4. Iovance Biotherapeutics Inc. (NASDAQ:IOVA)

Iovance climbed to a new 52-week high on Friday, extending a three-day run, as investors gobbled up shares after an investment firm doubled its price target for its stock.

At intra-day trading, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) climbed to its highest price of $5.34 before paring gains to finish the session just up by 12.01 percent at $5.13 apiece.

In a market report, UBS raised its price target for the biopharmaceutical company to $4 from $2 previously, albeit remaining “neutral” for the stock.

On the other hand, Iovance Biotherapeutics Inc. (NASDAQ:IOVA) maintained a more bullish rating from Wells Fargo, with the investment firm reaffirming its $14 price target and “buy” recommendation.

On Wednesday, March 11, investors will be closely watching out for business updates from Iovance Biotherapeutics Inc. (NASDAQ:IOVA) amid its participation in Barclays’ 28th Annual Global Healthcare Conference.

In recent news, the biopharmaceutical firm reported a 5 percent wider net loss last year at $390.98 million versus $372 million in 2024. Total revenues jumped by 60.6 percent to $263.5 million from $164.07 million year-on-year.

In the fourth quarter alone, net loss narrowed by 8 percent to $71.9 million from the $78.5 million in the same period a year earlier, while revenues increased by 17.6 percent to $86.7 million from $73.69 million year-on-year.